PROGNOSTIC BIOMARKER PSMD14 FACILITATES BLADDER CANCER TUMORIGENESIS AND PROGRESSION BY REGULATING NUCLEOLIN-YAP1 AXIS

Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis

Deubiquitinating enzymes (DUBs) significantly contribute to tumor progression and treatment resistance in bladder cancer.However, the mechanisms by which DUBs promote malignant behavior in patients with bladder cancer remain poorly understood.Using online databases such NEFF N70 KI1513F30G Integrated Tall Fridge as TCGA, GSE13507, and GSE23894, alo

read more